SCHEMBL14928320

SCHEMBL14928320

CCCOc1ncc(N)cc1-n1ccnn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.42
NOTUM Q6P988 7/20 0.36
EGLN2 Q96KS0 4/20 0.32
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TP53 P04637 1/20 0.31
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
CASP1 P29466 1/20 0.31
HTT P42858 1/20 0.31
CASP7 P55210 1/20 0.31
KMT2A Q03164 1/20 0.31
ATM Q13315 1/20 0.31
CDK1 P06493 1/20 0.30
CCNB1 P14635 1/20 0.30
CCNA2 P20248 1/20 0.30
CDK2 P24941 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14909636 0.89 CYP19A1 (0.38) CYP19A1NOTUMEGLN2POLBBRS3
SCHEMBL14910090 0.88 CYP19A1 (0.35) CYP19A1NOTUMEGLN2ALDH1A1
SCHEMBL3378540 0.83 NOTUM (0.41) CYP19A1NOTUMEGLN2ALDH1A1MAPT
SCHEMBL14928604 0.81 TDO2 (0.39) KDM4EMEN1USP2ALDH1A1TP53
SCHEMBL14928321 0.79 CYP19A1 (0.38) CYP19A1NOTUMEGLN2MEN1ALDH1A1
SCHEMBL16168981 0.77 KDM4E (0.34) KDM4EMEN1USP2ALDH1A1TP53
SCHEMBL14909053 0.75 NOTUM (0.42) CYP19A1NOTUMEGLN2
SCHEMBL14928355 0.70 BRAF (0.46) KDM4EGAAMAPT
SCHEMBL14928306 0.70 KDM4E (0.40) KDM4EMEN1USP2ALDH1A1TP53
SCHEMBL3378012 0.69 TDO2 (0.41) KDM4EMEN1ALDH1A1TP53GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK CYP19A1 3789/4885NOTUM 4306/4885EGLN2 3868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.